Welcome to chemicalbook!
+1 (818) 612-2111
Inquriy
Try our best to find the right business for you.
Do not miss inquiry messages Please log in to view all inquiry messages.

Welcome back!

RFQ
skype
MY Account
Top
Postion:Product Catalog >Pharmaceutical intermediates>Heterocyclic compound>(R)-3-AMINO-1-BUTANOL
(R)-3-AMINO-1-BUTANOL
  • (R)-3-AMINO-1-BUTANOL

(R)-3-AMINO-1-BUTANOL

Price Get Latest Price
Package 50kg 100kg
Min. Order: 25kg
Supply Ability: 1000000
Update Time: 2024-04-26

Product Details

Product Name: (R)-3-AMINO-1-BUTANOL CAS No.: 61477-40-5
Min. Order: 25kg Purity: 99.0%
Supply Ability: 1000000 Release date: 2024/04/26

This product is an intermediate of Dolutegravir.

Dolutegravir (DTG), trade name: TIVICAY, approved by the U.S. Food and Drug Administration on August 12, 2013, is a human immunodeficiency virus class Chemicalbook type 1(HIV-1) integrase chain transfer inhibitor (INSTI). It is suitable for the treatment of HIV-1 in adults and children over 12 years of age and at least 40kg of body mass in combination with other antiretroviral drugs.


This product is for research use only.

If  above  product   has  patent protection in your market , their price quoted will be invalid , and  all relevant  commerical actives must be stopped !

Company Profile Introduction

Enki Biopharmaceuticals (shanghai) Limited. is a cutting-edge pharmaceutical company committed to the comprehensive exploration, development, manufacturing, and commercialization of top-tier pharmaceutical products. The company established its state-of-the-art technology research and development center in Suzhou City, Jiangsu Province in 2016 and possesses production facilities located in Sichuan Province and Hunan Province. Enki Biopharma is propelled by technological research and development, with a primary focus on the R&D and production of high value-added and high-tech pharmaceutical intermediates/chiral compounds. The ultimate objective is to achieve industrialization through the creation of active pharmaceutical ingredients (APIs), while concurrently establishing core competencies in chiral synthesis, chemical/enzymatic catalysis, and clean production processes. The products primarily target premium foreign markets while simultaneously serving as intermediate support for domestic API production. Enki Biopharma embraces a market-oriented business philosophy, with innovation support and industrialization as its ultimate goals. It upholds the corporate spirit of focus, expertise, innovation, and win-win situations while remaining committed to the mission of creating value for customers, providing opportunities for employees, and promoting human health. Our utmost dedication lies in delivering high-quality products and premium services to our esteemed customers in order to achieve mutual success together. Simultaneously, we strive to foster employee development and promote social harmony.

Recommended supplier

Product name Price   Suppliers Update time
$5.00/1KG
VIP1Y
Henan Fengda Chemical Co., Ltd
2024-03-22
$0.00/25kg
VIP3Y
Shanghai Joiny Pharmaceutical Co.,LTD
2023-09-08
$0.00/1kg
VIP1Y
Hangzhou ICH Biofarm Co., Ltd
2023-07-03
$0.00/25Kg/Bag
VIP3Y
Sinoway Industrial co., ltd.
2023-04-20
$5.00/1KG
VIP3Y
Hebei Guanlang Biotechnology Co,.LTD
2023-04-18
$0.00/25kg
TAIZHOU DKD CHEMICAL CO., LTD.
2022-11-08
$0.00/1KG
VIP2Y
Henan Aochuang Chemical Co.,Ltd.
2022-10-13
$0.00/1KG
VIP3Y
WUHAN FORTUNA CHEMICAL CO., LTD
2021-10-21
$15.00/1KG
Zhuozhou Wenxi import and Export Co., Ltd
2021-07-10
$1.00/1PCS
VIP6Y
Hebei Guanlang Biotechnology Co., Ltd.
2021-04-12
  • Since: 2014-09-10
  • Address: Room 708, Building B(No. 2), No.125 Laiting South Road, Songjiang District, Shanghai,China
INQUIRY